Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHelios Underw Regulatory News (HUW)

Share Price Information for Helios Underw (HUW)

Share Price is delayed by 15 minutes
Get Live Data
214.50    0.00 (0.00%)
Bid:
211.00
Ask:
218.00
Spread: 7.00 (3.318%)
Market Cap: £146.49m
HUW Live PriceLast checked at - London Stock Exchange

Intraday Helios Underw Share Chart

Acquisition

5 Dec 2016 07:00

RNS Number : 8831Q
Helios Underwriting Plc
05 December 2016
 

5 December 2016

 

Helios Underwriting plc

("Helios" or the "Company")

 

Acquisition of Salviscount LLP

 

 

Acquisition of Salviscount LLP

 

Helios is pleased to announce that, in line with its strategy of increasing underwriting capacity through acquisition, on 2 December 2016 it acquired Salviscoint Limited Liability Partnership (Salviscount), a limited liability member of Lloyd's ("LLV"), for a consideration of £0.8 million in cash. The 2016 underwriting capacity of Salviscount is £1.0 million (this compares with Helios's 2016 capacity of £32.7 million prior to this acquisition). Salviscount participates in a spread of Lloyd's syndicates broadly similar to Helios's own participation. The capacity acquired, which Helios expects to retain, is as follows:

 

 Salviscount LLP

 

Year of Account

 

 

2014

2015

2016

 

£m

£m

£m

Retained

1.08

0.9

1.0

Reinsured

-

-

-

Total Capacity

1.08

0.9

1.0

 

 

Commenting upon the acquisition, Nigel Hanbury, the Company's Chief Executive Officer, said:

"We are delighted to have made a further acquisition which further increases our underwriting capacity. This is in line with our stated strategy of acquiring corporate members as suitable opportunities arise. We continue to believe that there remain significant opportunities for further growth available to the Company."

 

Additional information

Salviscount LLP (Salviscount) is a limited liability member of Lloyd's. In the year ended 31 December 2015, Salviscount made a profit before tax of £0.118m on gross premiums written of £0.881m and its net asset value at completion is expected to be approximately £0.8m, including underwriting capacity with an estimated market value of £0.4m.

 

 

Set out below are Salviscount's 2014 and 2015 open years of account forecasts:

 

YOA

Salviscount

syndicate capacity

(£'000)

Forecast of syndicate profit

(30 September 2016)

Mid point

(£'000)

Mid point

(%)

Range

(%)

2014

1,084

123

11.37

14.77% - 7.97%

2015

936

67

7.2%

11.19% - 3.20%

 

Source: Syndicate data and Helios analysis (before early release)

 

 

 

For further information please contact:

 

Helios

Nigel Hanbury - Chief Executive

Arthur Manners

 

020 7863 6655 / nigel.hanbury@huwplc.com

07754 965 917

 

 

Stockdale

Robert Finlay

 

 

020 7601 6100

 

 

 

About Helios

Helios provides a limited liability direct investment into the Lloyd's insurance market and is quoted on the London Stock Exchange's AIM market (ticker: HUW). Helios trades within the Lloyd's insurance market writing approximately £32 million of capacity for the 2016 account. The portfolio provides a good spread of classes of business being concentrated in property insurance and reinsurance. For further information please visit www.huwplc.com.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQTTBRTMBJMBIF
Date   Source Headline
2nd Feb 20217:00 amRNSDirector/PDMR Shareholding
18th Jan 20217:00 amRNSAppointment of Financial Adviser
1st Dec 20207:00 amRNSHolding(s) in Company
1st Dec 20207:00 amRNSHolding(s) in Company
1st Dec 20207:00 amRNSMaterial Capacity Increase
30th Nov 20209:57 amRNSHolding(s) in Company
30th Nov 20207:00 amRNSHolding(s) in Company
30th Nov 20207:00 amRNSHolding(s) in Company
26th Nov 20203:40 pmRNSResult of GM, TVR and Directors' Participations
24th Nov 20207:00 amRNSResult of Open Offer
19th Nov 20207:00 amRNSQuarterly Syndicate Mid-Point Forecasts
2nd Nov 20207:00 amRNSPlacing, Subscription, Open Offer & Acquisitions
7th Oct 20207:00 amRNSProposed Fundraising
25th Sep 20207:00 amRNSHalf-year Report
17th Aug 20207:00 amRNSQuarterly Syndicate Mid-Point Forecasts
10th Aug 20207:00 amRNSUpdate on Capacity and Growth Plans
25th Jun 202012:38 pmRNSResult of AGM
3rd Jun 20207:00 amRNSDirector/PDMR Shareholding
2nd Jun 20207:00 amRNSPosting of Annual Report and Notice of AGM
1st Jun 202012:28 pmRNSHolding(s) in Company
1st Jun 20207:30 amRNSDirector/PDMR Shareholding
29th May 20207:00 amRNSFinal results for the year ended 31 December 2019
30th Mar 20207:00 amRNSQuarterly Syndicate Mid-point Forecasts
29th Jan 20207:00 amRNSCapacity Update and Transaction in Own Shares
13th Dec 20197:00 amRNSAcquisition
18th Nov 20197:00 amRNSQuarterly Syndicate Mid-point Forecasts
7th Oct 20197:00 amRNSTransaction in Own Shares and Total Voting Rights
27th Sep 20197:00 amRNSHalf-year Report
16th Sep 20197:00 amRNSTransaction in Own Shares and Total Voting Rights
2nd Sep 20199:39 amRNSReplacement- Transaction in Own Shares
2nd Sep 20197:00 amRNSTransaction in Own Shares and Total Voting Rights
19th Aug 20197:00 amRNSTransaction in Own Shares
16th Aug 20197:00 amRNSQuarterly Syndicate Mid-point Forecasts
15th Aug 20194:28 pmRNSHolding(s) in Company
12th Aug 20197:00 amRNSProposed Ordinary Share repurchases
19th Jul 20198:47 amRNSHolding(s) in Company
16th Jul 20191:00 pmRNSResult of Meeting
28th Jun 20193:13 pmRNSResult of AGM
13th Jun 20197:00 amRNSChange of Adviser
13th Jun 20197:00 amRNSFundraising, Acquisition, Waiver & Notice of GM
31st May 20197:00 amRNSFinal results for the year ended 31 December 2018
30th May 20192:14 pmRNSDirector's Disclosure
17th May 20197:00 amRNSQuarterly Syndicate Mid-point Forecasts
10th May 20199:30 amRNSTrading Update
29th Mar 20197:00 amRNSQuarterly Syndicate Mid-point Forecasts
29th Jan 20197:00 amRNSDirector Dealing
23rd Jan 20197:00 amRNSTransaction in Own Shares and Total Voting Rights
21st Jan 20197:00 amRNSTransaction in Own Shares and Total Voting Rights
17th Jan 20197:00 amRNSTransaction in Own Shares and Total Voting Rights
14th Jan 20197:00 amRNSTransaction in Own Shares and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.